Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination?
Autor*in: |
Bassat, Quique [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017 |
---|
Umfang: |
2 |
---|
Übergeordnetes Werk: |
Enthalten in: Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model - Berhane, S. ELSEVIER, 2016, New York, NY |
---|---|
Übergeordnetes Werk: |
volume:17 ; year:2017 ; number:2 ; pages:121-122 ; extent:2 |
Links: |
---|
DOI / URN: |
10.1016/S1473-3099(16)30459-5 |
---|
Katalog-ID: |
ELV030296145 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV030296145 | ||
003 | DE-627 | ||
005 | 20230623204427.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/S1473-3099(16)30459-5 |2 doi | |
028 | 5 | 2 | |a GBV00000000000263A.pica |
035 | |a (DE-627)ELV030296145 | ||
035 | |a (ELSEVIER)S1473-3099(16)30459-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.44 |2 bkl | ||
100 | 1 | |a Bassat, Quique |e verfasserin |4 aut | |
245 | 1 | 0 | |a Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
264 | 1 | |c 2017 | |
300 | |a 2 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
700 | 1 | |a Menéndez, Clara |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Berhane, S. ELSEVIER |t Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |d 2016 |g New York, NY |w (DE-627)ELV013808834 |
773 | 1 | 8 | |g volume:17 |g year:2017 |g number:2 |g pages:121-122 |g extent:2 |
856 | 4 | 0 | |u https://doi.org/10.1016/S1473-3099(16)30459-5 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_26 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_70 | ||
936 | b | k | |a 44.44 |j Parasitologie |x Medizin |q VZ |
951 | |a AR | ||
952 | |d 17 |j 2017 |e 2 |h 121-122 |g 2 | ||
953 | |2 045F |a 610 |
author_variant |
q b qb |
---|---|
matchkey_str |
bassatquiquemenndezclara:2017----:iyratmsnnieauniiwrsocnrlawu |
hierarchy_sort_str |
2017 |
bklnumber |
44.44 |
publishDate |
2017 |
allfields |
10.1016/S1473-3099(16)30459-5 doi GBV00000000000263A.pica (DE-627)ELV030296145 (ELSEVIER)S1473-3099(16)30459-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Bassat, Quique verfasserin aut Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? 2017 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Menéndez, Clara oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:17 year:2017 number:2 pages:121-122 extent:2 https://doi.org/10.1016/S1473-3099(16)30459-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 17 2017 2 121-122 2 045F 610 |
spelling |
10.1016/S1473-3099(16)30459-5 doi GBV00000000000263A.pica (DE-627)ELV030296145 (ELSEVIER)S1473-3099(16)30459-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Bassat, Quique verfasserin aut Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? 2017 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Menéndez, Clara oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:17 year:2017 number:2 pages:121-122 extent:2 https://doi.org/10.1016/S1473-3099(16)30459-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 17 2017 2 121-122 2 045F 610 |
allfields_unstemmed |
10.1016/S1473-3099(16)30459-5 doi GBV00000000000263A.pica (DE-627)ELV030296145 (ELSEVIER)S1473-3099(16)30459-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Bassat, Quique verfasserin aut Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? 2017 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Menéndez, Clara oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:17 year:2017 number:2 pages:121-122 extent:2 https://doi.org/10.1016/S1473-3099(16)30459-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 17 2017 2 121-122 2 045F 610 |
allfieldsGer |
10.1016/S1473-3099(16)30459-5 doi GBV00000000000263A.pica (DE-627)ELV030296145 (ELSEVIER)S1473-3099(16)30459-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Bassat, Quique verfasserin aut Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? 2017 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Menéndez, Clara oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:17 year:2017 number:2 pages:121-122 extent:2 https://doi.org/10.1016/S1473-3099(16)30459-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 17 2017 2 121-122 2 045F 610 |
allfieldsSound |
10.1016/S1473-3099(16)30459-5 doi GBV00000000000263A.pica (DE-627)ELV030296145 (ELSEVIER)S1473-3099(16)30459-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Bassat, Quique verfasserin aut Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? 2017 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Menéndez, Clara oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:17 year:2017 number:2 pages:121-122 extent:2 https://doi.org/10.1016/S1473-3099(16)30459-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 17 2017 2 121-122 2 045F 610 |
language |
English |
source |
Enthalten in Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model New York, NY volume:17 year:2017 number:2 pages:121-122 extent:2 |
sourceStr |
Enthalten in Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model New York, NY volume:17 year:2017 number:2 pages:121-122 extent:2 |
format_phy_str_mv |
Article |
bklname |
Parasitologie |
institution |
findex.gbv.de |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
authorswithroles_txt_mv |
Bassat, Quique @@aut@@ Menéndez, Clara @@oth@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
ELV013808834 |
dewey-sort |
3610 |
id |
ELV030296145 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV030296145</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623204427.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1473-3099(16)30459-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000263A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV030296145</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1473-3099(16)30459-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.44</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bassat, Quique</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menéndez, Clara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Berhane, S. ELSEVIER</subfield><subfield code="t">Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model</subfield><subfield code="d">2016</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV013808834</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:121-122</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1473-3099(16)30459-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.44</subfield><subfield code="j">Parasitologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2017</subfield><subfield code="e">2</subfield><subfield code="h">121-122</subfield><subfield code="g">2</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Bassat, Quique |
spellingShingle |
Bassat, Quique ddc 610 bkl 44.44 Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
authorStr |
Bassat, Quique |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV013808834 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 44.44 bkl Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
topic |
ddc 610 bkl 44.44 |
topic_unstemmed |
ddc 610 bkl 44.44 |
topic_browse |
ddc 610 bkl 44.44 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
c m cm |
hierarchy_parent_title |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
hierarchy_parent_id |
ELV013808834 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV013808834 |
title |
Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
ctrlnum |
(DE-627)ELV030296145 (ELSEVIER)S1473-3099(16)30459-5 |
title_full |
Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
author_sort |
Bassat, Quique |
journal |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
journalStr |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
zzz |
container_start_page |
121 |
author_browse |
Bassat, Quique |
container_volume |
17 |
physical |
2 |
class |
610 610 DE-600 610 VZ 44.44 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Bassat, Quique |
doi_str_mv |
10.1016/S1473-3099(16)30459-5 |
dewey-full |
610 |
title_sort |
dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
title_auth |
Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 |
container_issue |
2 |
title_short |
Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
url |
https://doi.org/10.1016/S1473-3099(16)30459-5 |
remote_bool |
true |
author2 |
Menéndez, Clara |
author2Str |
Menéndez, Clara |
ppnlink |
ELV013808834 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth |
doi_str |
10.1016/S1473-3099(16)30459-5 |
up_date |
2024-07-06T17:12:53.584Z |
_version_ |
1803850585037864960 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV030296145</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623204427.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1473-3099(16)30459-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000263A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV030296145</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1473-3099(16)30459-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.44</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bassat, Quique</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menéndez, Clara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Berhane, S. ELSEVIER</subfield><subfield code="t">Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model</subfield><subfield code="d">2016</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV013808834</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:121-122</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1473-3099(16)30459-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.44</subfield><subfield code="j">Parasitologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2017</subfield><subfield code="e">2</subfield><subfield code="h">121-122</subfield><subfield code="g">2</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.3995466 |